Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Secondary Lymphedema
Interventions: DRUG: Lymfactin® (1x10E11 vp)|DRUG: Placebo
Sponsor: Herantis Pharma Plc.